Shiven Bharat Patel MD MBA, FACP

Hematologic Oncology, Thoracic Cancer

Physician

1950 Circle of Hope Dr# ClinicSalt Lake City, UT 84112
Phone+1 801-585-0100
Fax+1 801-585-1312

Dr. Patel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Patel's full profile Already have an account?

Education & Training

Indiana University – Purdue University IndianapolisM.B.A., Business of Medicine Program, 2015 - 2017
University of Utah HealthFellowship, Hematology and Medical Oncology, 2012 - 2015
University of MarylandResidency, Internal Medicine, 2008 - 2011
University of Florida College of MedicineClass of 2008
University of FloridaB.S., Major: Basic Biology and Medicine; Minor: Business Administration, 2001 - 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

UT State Medical License 2012 - 2028
ID State Medical License 2017 - 2027
MT State Medical License 2025 - 2027
NV State Medical License 2025 - 2027
WY State Medical License 2025 - 2027
MD State Medical License 2011 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016
Anderson Scholar University of Florida College of Liberal Arts and Sciences, 2004

Publications & Presentations

PubMed

1 citations
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026.
Apar Kishor P Ganti, Billy W Loo Jr, Shahed Badiyan, Michael Bassetti, Christine Bestvina
Journal of the National Comprehensive Cancer Network. 2026-01-01
1 citations
Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung Cancer.
Yeonjung Jo, Sonam Puri, Benjamin Haaland, Adriana M Coletta, Jonathan J Chipman
Clinical Lung Cancer. 2025-01-01
4 citations
Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b ...
Joel W Neal, Armando Santoro, Maria Gonzalez-Cao, Farah Louise Lim, Bruno Fang
JTO Clinical and Research Reports. 2024-10-01

Journal Articles

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma
Kuzman JA, Stenehjem DD, Merriman J, Agarwal AM, Patel SB, Hahn AW, Alex A, Albertson D, Gill DM, Agarwal N, BMC Urology, 1/1/2017
Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular en...
Bailey EB, Merriman J, Maughan B, Poole A, Tantravahi SK, Agarwal AM, Batten JA, Patel SB, Pal SK, Stenehjem DD, Agarwal N, Journal of Oncology Pharmacy Practice, 1/1/2017
Myeloid Growth Factors, Version 22017, NCCN Clinical Practice Guidelines in Oncology
Crawford J, Becker PS, Armitage JO, Blayney DW, Chavez J, Curtin P, Dinner S, Fyan T, Gojo I, Griffiths EA, Hough S, Kloth DD, Kuter DJ, Lyman GH, Mably M, Mukherjee S..., Journal of the National Comprehensive Cancer Network, 1/1/2017

Abstracts/Posters

Association of time from definitive therapy (DT) to start of androgen deprivation therapy (ADT) for metastatic disease and survival outcomes in men with new metastatic...
Gill DM, Stenehjem DD, Cheng HH, Kessler ER, Hahn AW, Gupta S, Alex A, Patel SB, Chittoria N, Twardowski P, Vaishampayan UN, Agarwal N, Journal of Clinical Oncology, 1/1/2017
Neutrophil-lymphocyte ratio (NLR) as a predictive biomarker for response to high dose interleukin 2 (HDIL-2) in patients with metastatic renal cell carcinoma (mRCC).
Kuzman JA, Stenehjem DD, Patel SB, Merriman J, Gill DM, Hahn A, Agarwal AM, Gupta S, Albertson D, Alex A, Agarwal N, Journal of Clinical Oncology, 1/1/2016
Association of single nucleotide polymorphisms (SNPs) in STS and SULT2B1 and response to androgen deprivation therapy (ADT) in men with advanced hormone sensitive pros...
Agarwal N, Buckley TH, Farnham JM, Patel SB, Agarwal A, Tantravahi SK, Teerlink C, Albright FS, Stephenson RA, Alex A, Cannon-Albright LA, Clinical Cancer Research, 1/1/2016

Lectures

Risk stratification using patient-reported outcomes (PROs) in patients (pts) with advanced cancer.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Oncologic Emergencies
1/1/2018
Lung Cancer
Veterans Affairs Hospital, University of Utah - 1/1/2017

Press Mentions

In the Wake of Big FDA Approvals, What Advances in SCLC Care Are in Store for 2026?January 14th, 2026
The Biggest Reimbursement Challenges in Oncology: 6 Leaders Weigh InDecember 7th, 2020
Navigating Treatment Decisions with Immunotherapy in Squamous NSCLCOctober 11th, 2019